Model Informed Drug Development Archives

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

On-Demand Webinar

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

ToxStudio integrates safety and toxicology software to address three critical areas in preclinical safety: Cardiac…

CertaraDecember 19, 2023

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Publication

Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper

The promise of viral vector-based gene therapy (GT) as a transformative paradigm for treating severely…

CertaraJune 14, 2023

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

CertaraMay 24, 2023

Conference

ACoP 2026

CertaraMay 24, 2023

Conference

ISPOR International Annual Conference 2026

–

CertaraFebruary 15, 2023

Conference

2026 ACCP Annual Meeting

–

CertaraJuly 15, 2022

Publication

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often,…

CertaraSeptember 23, 2021

Press Coverage

How New FDA Guidance Project Optimus May Affect Future of Oncology Clinical Trials, Drug Pipeline

Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the…

CertaraAugust 16, 2021

Model Informed Drug Development

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-Based Gene Therapy Product Development: A White Paper

American College of Toxicology 2026 Annual Meeting

ACoP 2026

ISPOR International Annual Conference 2026

2026 ACCP Annual Meeting

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

How New FDA Guidance Project Optimus May Affect Future of Oncology Clinical Trials, Drug Pipeline

Newsletter sign up

Quick links

Solutions

Contact